Lyon Joseph Douglas

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(4%)0%0%0%0%
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3
Drugs » Biotechnology

Chief Accounting Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($1.23M) Net Amount
Buy:0--
Sell:($1.23M)$23.88 - $25.21